All News

I couldn't figure out how to fit in before this post. I read the blogs in the CURE community of contributors and I read the articles on the CURE home page — nothing.

In a world where cancer means loss, can letting go bring peace and joy?

A survivor of breast cancer and melanoma reflects on her simple New Year's resolutions.

This time of year, one of the traditions that coincides with resolutions, is the reflection on what we have to be thankful for. This experience — counting blessings, giving thanks, the gratitude attitude — can be challenging.

Staying hopeful when others are dying of the same disease is one of the most challenging aspects of cancer.

A cancer survivor and clutter clearing expert shares ways to clear the holiday clutter.

The FDA has expanded the approval for single-agent Keytruda to include the frontline treatment of patients with advanced melanoma regardless of BRAF status and to include the treatment of patients with Yervoy-refractory melanoma.

For survivors of cancer, screening intensively for recurrences may be less beneficial than simply striving for good overall health.

Fit older patients can often get the same cancer treatments as their younger counterparts, but additional conditions such as heart disease or diabetes signal the need for caution.

Intimacy in the life of a breast cancer survivor can be difficult, but it's not impossible.

In keeping a chronology of our moments of illness, we find ways to commemorate our life moments, both good and bad. We learn who we are, who we want to be and who we will become.

The CD38 monoclonal antibody Darzalex demonstrated a 31 percent overall response rate as monotherapy for patients with heavily pretreated multiple myeloma.

An all orally administered regimen containing Ninlaro, Revlimid and dexamethasone showed a 5.9-month improvement in progression-free survival compared with Revlimid and dexamethasone alone.

Never underestimate the power and inner strength of a hungry cancer patient.

A male breast cancer survivor recalls remarkable gifts of goodwill.

A breast cancer survivor wonders when it will be “safe” to toss the chemo wig and reflects about going down the road as a cancer survivor.

All of the women in the study had progressed on two or more HER2-targeted therapies, including Herceptin (trastuzumab) and Tykerb (lapatinib).

Gene therapy has the potential to deliver long-lasting remissions for patients with advanced B-cell malignancies who already have undergone an allogeneic hematopoietic stem cell transplant.

My letter to Ty, a young man taken before his time.

Here are some important tips for cancer patients and caregivers to reduce stress, take care of themselves and enjoy the season.

I will never forget the emotions

The agent was approved as a treatment for patients with metastatic ALK-positive non-small cell lung cancer (NSCLC).

The FDA's decision was based on two studies that measured the 30-day survival rate of adult and pediatric patients who had either overdosed on treatment or were experiencing early-onset toxicities.

Less than two years after Imbruvica gained approval for patients with CLL, a second-generation agent has demonstrated a 95 percent response rate.

I have stage 4 lung cancer. Here are 24 other things about me.

"We now finally have evidence that bone-targeted treatment is not only successful in treating bony metastases and preventing treatment-induced bone loss," said Michael Gnant.

The Screen This Too! campaign, created by the Colon Cancer Alliance, expands the awareness and prevention conversation. Simple in concept, broad in scope

A study released by the international nonprofit Cancer Support Community found that more than half of patients with cancer feel unprepared to discuss treatment options with their medical team, a significant finding given the high burden patients with cancer carry across a number of dimensions.

Cancer Support Community tackles the CLL experience in new cancer experience registry.

A study by the Cancer Support Community examined the factors that are most influential when patients choose a particular treatment option.